Recent Quotes (30 days)

You have no recent quotes
chg | %

Promis Neurosciences Inc  

(Public, TSE:PMN)   Watch this stock  
Find more results for TSE:amf
0.0800
+0.0150 (23.08%)
Aug 4 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.07 - 0.09
52 week 0.04 - 0.09
Open 0.08
Vol / Avg. 93,200.00/111,781.00
Mkt cap 9.64M
P/E     -
Div/yield     -
EPS -0.03
Shares 119.12M
Beta -0.16
Inst. own     -
May 25, 2015
Q1 2015 Amorfix Life Sciences Ltd Earnings Release
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -818.36% -1519.24%
Operating margin -818.36% -1519.24%
EBITD margin - -1508.23%
Return on average assets -660.99% -458.43%
Return on average equity - -
CDP Score - -

Address

Suite 200, 1920 Yonge Street
MISSISSAUGA, ON M4S 3E2
Canada
+1-416-8476898 (Phone)
+1-416-8476899 (Fax)

Website links

Description

Promis Neurosciences Inc, formerly Amorfix Life Sciences Ltd, is a Canada-based company, engaged in discovering and developing precision medicine solutions. The Company is focused on therapeutic antibodies and diagnostics for the diagnosis and treatment of misfolded protein diseases, including amyotrophic lateral sclerosis (ALS), cancer and Alzheimer's disease (AD). Its technology includes the Epitope Protection technology, ProMIS and AMFIA. Its technology targets misfolded superoxide dismutase 1 (SOD1) through a passive infusion of manufactured monoclonal antibodies and an active immunization approach to elicit the production of similar antibodies by the patient's own immune system. It is engaged in the development of a blood test that measures misfolded SOD1 in blood, for the diagnosis of ALS. It has developed a preclinical test for detection and measurement of aggregated Abeta, in animal models and a test for the detection of aggregated Abeta in human clinical samples.

Officers and directors

Eugene Williams Executive Chairman of the Board
Robert Gundel Ph.D. President, Chief Executive Officer, Director, IR Contact Officer
Neil Cashman M.D. Chief Scientific Officer, Director
Warren Whitehead Chief Financial Officer, Director
Elliot Goldstein M.D. Director
Age: 64
Johannes M. Roth Independent Director
Age: 36